Skip to content

4Accepted Aug 11, 8:40 PM ET

Femasys (FEMY) COO John Canning Buys 4,375 Shares

FEMYFEMASYS INC

Accepted (ET)

8:40 PM

Aug 11, 2026

Filed

Aug 11, 2026

Documents

1

Size

10.6 KB

Summary

Femasys (FEMY) COO John Canning Buys 4,375 Shares

Updated

What Happened

  • John Charles Canning, Chief Operating Officer of Femasys Inc. (FEMY), purchased 4,375 common shares in an open-market/private placement on August 7, 2026 at $3.20 per share for a total cash outlay of $14,000. On the same date he also acquired two derivative awards (reported as grants) tied to 4,375 shares each (these are warrants/other derivative securities, not immediate common-stock issuances).

Key Details

  • Transaction date: August 7, 2026; Form 4 filed August 11, 2026 (filed on the second business day — appears timely).
  • Open-market/private purchase: 4,375 shares at $3.20, aggregate $14,000 (Footnotes F1, F4).
  • Two derivative awards reported (each for 4,375 share-equivalents) — described as warrants/derivative securities (no immediate per-share cash price reported).
  • Common Warrant terms: exercisable at $2.95 per share (subject to adjustment and Nasdaq limitations) (F2, F3).
  • Milestone Warrant: exercisable only after a Milestone Date (first date on/after Aug 10, 2027 when specified U.S. revenue and price conditions are met); expiration and exact timing undeterminable as of this filing (F5).
  • Shares owned after the transaction: not specified in this filing.

Context

  • The cash purchase of common shares is a straightforward buy (often regarded as a more informative signal than routine sales), while the two awards are derivative warrants that may only convert into common shares if/when exercised and conditions are met. The milestone-based warrant has additional revenue and stock-price triggers and cannot be exercised until those conditions occur (no immediate sale or cashless exercise is reported).

AI-written summary · check the filing